Aura Biosciences, Inc.

AURA

Held by 4 specialist biotech funds

High ConvergenceHigh short interest · No specialist buying

4 funds opened new positions. Short interest: 6.0% of float.

Share

Signal Score

5.0/10

4 funds opened new positions●●

No recent insider activity●●

No upcoming catalysts●●

Held by 4 specialist funds●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

4 fund convergence

OrbiMed AdvisorsNew

Redmile GroupNew

RA Capital ManagementNew

EcoR1 CapitalNew

Short Interest

High short interest

Short Shares

6.16M

Change

+9.8%

Days to Cover

12.9

% of Float

6.0%

Settlement

Aug 14, 2026

Short interest over 11 periods

Catalysts

No catalysts tracked.

Be first to know when this name moves

Fund buys and exits, insider activity, and catalyst alerts across 800+ biotechs — free Monday brief.

Activist Filings

SC 13G/AEventide Asset Management0.0%May 14, 2025

SC 13G/AEventide Asset Management0.0%May 13, 2025

SC 13G/AEventide Asset Management8.2%Feb 14, 2025

SC 13G/AEventide Asset Management11.8%Dec 11, 2023

SC 13GEventide Asset Management6.3%Feb 14, 2023

Position Details

OrbiMed AdvisorsNEW POSITIONAug 14, 2026

Start free trialfor share counts, dollar values & AI analysis

3 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Also Held by These Funds

JANX1 fund BIOA1 fund BNTC1 fund CAPR1 fund CCCC1 fund CLYM1 fund COAG1 fund CRVS1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer